Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.14 +0.75 (+2.75%)
As of: Nov 11, 2026 · 11:14 AM EST

Arcutis Biotherapeutics (ARQT) Return on Assets [ROA] (2020 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) recorded Return on Assets [ROA] of 6.01% in Q2 2026, up 32.79 percentage points from -26.78% a year earlier and up 6.55 percentage points from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Arcutis Biotherapeutics reported Return on Assets [ROA] of -4.14%, up 36.44 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for three straight years, with a five-year change of +63.30 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -40.58% in FY2024 (+25.73 pp), -66.31% in FY2023 (+6.34 pp), -72.65% in FY2022 (-14.23 pp) and -58.42% in FY2021 (+9.01 pp).
  • The Q2 2026 figure is the highest quarterly Return on Assets [ROA] in data going back to Q1 2020.
  • On a year-over-year basis, Return on Assets [ROA] has increased for ten consecutive quarters, with an average year-over-year change of +31.90 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 51.44 percentage points in Q2 2024, against a drop of 45.15 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -0.54% (Q1 2026), -4.02% (Q4 2025) and -12.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn 5.81%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.81%
Jun 30, 2026 5.91%
Mar 31, 2026 -0.62%
Dec 31, 2025 -4.03%
Sep 30, 2025 -12.41%
Jun 30, 2025 -26.71%
Mar 31, 2025 -37.44%
Dec 31, 2024 -35.63%
Sep 30, 2024 -44.17%
Jun 30, 2024 -43.06%
Mar 31, 2024 -52.97%
Dec 31, 2023 -82.31%
Sep 30, 2023 -86.85%
Jun 30, 2023 -94.23%
Mar 31, 2023 -78.83%
Dec 31, 2022 -65.18%
Sep 30, 2022 -77.18%
Jun 30, 2022 -78.62%
Mar 31, 2022 -61.04%
Dec 31, 2021 -51.97%
API Access

Arcutis Biotherapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY